PMC:7561592 / 11152-11599 JSONTXT

{"target":"http://pubannotation.org/docs/sourcedb/PMC/sourceid/7561592","sourcedb":"PMC","sourceid":"7561592","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7561592","text":"Mesalazine Salofalk® Dr. Falk Pharma (UK) Granules/delayed release pH-dependent Aspartame (E 951), carmellose sodium, cellulose, citric acid, silica, hypromellose, magnesium stearate, Eudragit L 100, Eudragit NE 40 D containing 2% nonoxynol 100, povidone K 25, simeticone, sorbic acid, talc, titanium dioxide (E 171), triethyl citrate, vanilla custard flavour 135 Granules should be placed on the tongue and washed down with water without chewing.","divisions":[{"label":"td","span":{"begin":0,"end":10}},{"label":"td","span":{"begin":11,"end":20}},{"label":"td","span":{"begin":21,"end":41}},{"label":"td","span":{"begin":42,"end":79}},{"label":"td","span":{"begin":80,"end":359}},{"label":"td","span":{"begin":360,"end":363}}],"tracks":[]}